Evidence map›Paper›PMID 40610935›Full record

ArticleBMC public health2025

Prevalence and associated factors of adherence to antihypertensive medication: a nationwide cross-sectional study.

Muhammad Arshed, Mehwish Kiran, Muhammad Farooq Umer, Jamil Adnan Samkari, Syed Mehmood Ul Hassan, Shafqat Qamer, Ali Hassan Gillani, Sajid Hameed, Waseela Ashraf, Hasan Mujtaba and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Muhammad ArshedDepartment of Community Medicine, Baqai Medical College, Baqai Medical University, Karachi, Pakistan.
Mehwish KiranDepartment of Gynaecology and Obstetrics, Punjab Employees Social Security Institute, Lahore, Pakistan.
Muhammad Farooq UmerPreventive Dental Sciences Department, College of Dentistry, King Faisal University, Al-Ahsa, 31982, Hofuf, Saudi Arabia.
Jamil Adnan SamkariDepartment of Family and Community Medicine, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia.
Syed Mehmood Ul HassanDepartment of Medicine, Services Hospital, Medical Unit 1, Lahore, Pakistan.
Shafqat QamerDepartment of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
Ali Hassan GillaniDepartment of Pharmacy Administration and Clinical Pharmacy, Xi'an Jiaotong University, Xi'an, China.
Sajid HameedDepartment of Public Health, Green International University, Lahore, Pakistan.
Waseela AshrafFaculty of Allied Health Sciences, University Institute of Public Health, The University of Lahore, Lahore, Pakistan.
Hasan MujtabaSchool of Dentistry, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PIMS, G-8/3, Pakistan.
Muhammad Naseem KhanDepartment of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar. naseem@qu.edu.qa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypertension is the leading modifiable risk factor for cardiovascular diseases, contributing significantly to global morbidity and mortality. Despite advancements in antihypertensive therapies, adherence to medication remains alarmingly low, particularly in low- and middle-income countries. There is limited representative research in Pakistan on adherence rates and associated factors, necessitating a comprehensive investigation.

objectiveTo determine the prevalence of adherence to antihypertensive medication and identify factors influencing adherence among hypertensive patients across Pakistan.

methodsA nationwide cross-sectional study was conducted between September 2021 and January 2023 across 225 healthcare facilities in Pakistan. A multistage random sampling strategy recruited 32,197 hypertensive patients. Adherence was assessed using the Self-Efficacy for Appropriate Medication Scale (SEAMS) and pill count methods. Multivariable binary regression analysis identified sociodemographic and clinical predictors of adherence.

resultsAdherence to antihypertensive medication was observed in only 36.6% of hypertensive patients, with significant regional and demographic variations. Factors positively associated with adherence to antihypertensive medications include male gender (AOR = 4.64, 95% CI [1.53-14.11]), graduate education compared to postgraduate education (AOR = 1.23, 95% CI [1.08-1.39]), higher daily medication (> 9) compared to less (< 5) medications (AOR = 2.00; 95% CI [1.84-2.19]), higher daily dose frequency compared to single dose, and higher monthly income compared to less than 25,000/month. Conversely, negative associations include primary/secondary education to postgraduate (AOR = 0.16, 95% CI [0.14-0.18]), single marital status compared to married (AOR = 0.02 95% CI [0.01-0.04]), more than one comorbid condition (AOR = 0.81, 95% CI [0.74-0.89], smoking (AOR = 0.09, 95% CI[0.08-0.10]), uncontrolled hypertension (AOR = 0.74, 95% CI [0.69-0.78), and the rest of the regions compared to Islamabad.

conclusionThese findings highlight the complex interplay of demographics, medication patterns, and economic factors in medication adherence with very low adherence rates in Pakistan. Targeted, context-specific interventions-addressing affordability, education, and better awareness could potentially improve the adherence rates.

Indexed as

Antihypertensive AgentsHypertensionMedication AdherenceAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPakistanPrevalenceRisk FactorsSocioeconomic FactorsAntihypertensive AgentsAntihypertensiveCross-sectionalMedication adherencePakistanRisk factors

Identifiers

PMID40610935
PMCPMC12224808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.